Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.

Winkler, Martin Sebastian; Korsten, Peter; Binder, Claudia; Tampe, Björn

Winkler, Martin Sebastian; Korsten, Peter; Binder, Claudia; Tampe, Björn.

Afiliação

Winkler MS; Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany.
Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Binder C; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Tampe B; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany bjoern.tampe@med.uni-goettingen.de.

Ann Rheum Dis ; 82(8): e182, 2023 Aug.

Article em En | MEDLINE | ID: mdl-32958511

Assuntos

COVID-19; Humanos; Estudos de Casos e Controles; Tratamento Farmacológico da COVID-19; Receptores de Interleucina-6; Resultado do Tratamento

Palavras-chave

anti-inflammatory agents; biological therapy; cytokines; immune system diseases; inflammation; non-steroidal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article